Selling And Administration Expenses 更改
AbbVie USD 3.29B 562M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.57M 397K 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
DBV Technologies USD 4.31M 685K 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Neurocrine Biosciences USD 276.5M 11.3M 2025-03
Novartis USD 3.44B 384M 2025-06


Amarin 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jul 2025.